Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Keyur Shah, M.D.
Chief of the Section of Heart Failure
Virginia Commonwealth University
Poster(s):
(M1230-05-28) Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results from the ATTRibute-CM Study
Monday, November 10, 2025
12:30 PM - 1:30 PM
CT
(M1330-05-28) Acoramidis Effect on All-Cause Mortality in Patients with p.V142I (V122I) Variant ATTR-CM: Findings from the ATTRibute-CM Study
Monday, November 10, 2025
1:30 PM - 2:30 PM
CT
